ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
908 Devices Inc

908 Devices Inc (MASS)

5.42
0.02
( 0.37% )
Updated: 12:35:08

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
5.42
Bid
5.39
Ask
5.43
Volume
81,969
5.325 Day's Range 5.52
1.81 52 Week Range 7.4802
Market Cap
Previous Close
5.40
Open
5.40
Last Trade
1
@
5.43
Last Trade Time
12:43:05
Financial Volume
$ 443,013
VWAP
5.4046
Average Volume (3m)
3,062,710
Shares Outstanding
35,329,993
Dividend Yield
-
PE Ratio
-2.66
Earnings Per Share (EPS)
-2.04
Revenue
59.63M
Net Profit
-72.21M

About 908 Devices Inc

908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, a... 908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Show more

Sector
Meas & Controlling Dev, Nec
Industry
Meas & Controlling Dev, Nec
Headquarters
Wilmington, Delaware, USA
Founded
-
908 Devices Inc is listed in the Meas & Controlling Dev sector of the NASDAQ with ticker MASS. The last closing price for 908 Devices was $5.40. Over the last year, 908 Devices shares have traded in a share price range of $ 1.81 to $ 7.4802.

908 Devices currently has 35,329,993 shares outstanding. The market capitalization of 908 Devices is $190.78 million. 908 Devices has a price to earnings ratio (PE ratio) of -2.66.

MASS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.8719.12087912094.555.944.478568555.24072607CS
41.3733.82716049384.055.943.556750594.41470189CS
123.04127.7310924372.385.941.9230627103.83079002CS
262.0761.79104477613.355.941.8117688663.62138841CS
52-0.13-2.342342342345.557.48021.819724023.77932143CS
156-12.62-69.95565410218.04261.814847896.32992103CS
260-40.09-88.090529553945.5179.61.8142570012.75739003CS

MASS - Frequently Asked Questions (FAQ)

What is the current 908 Devices share price?
The current share price of 908 Devices is $ 5.42
How many 908 Devices shares are in issue?
908 Devices has 35,329,993 shares in issue
What is the market cap of 908 Devices?
The market capitalisation of 908 Devices is USD 190.78M
What is the 1 year trading range for 908 Devices share price?
908 Devices has traded in the range of $ 1.81 to $ 7.4802 during the past year
What is the PE ratio of 908 Devices?
The price to earnings ratio of 908 Devices is -2.66
What is the cash to sales ratio of 908 Devices?
The cash to sales ratio of 908 Devices is 3.22
What is the reporting currency for 908 Devices?
908 Devices reports financial results in USD
What is the latest annual turnover for 908 Devices?
The latest annual turnover of 908 Devices is USD 59.63M
What is the latest annual profit for 908 Devices?
The latest annual profit of 908 Devices is USD -72.21M
What is the registered address of 908 Devices?
The registered address for 908 Devices is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the 908 Devices website address?
The website address for 908 Devices is www.908devices.com
Which industry sector does 908 Devices operate in?
908 Devices operates in the MEAS & CONTROLLING DEV, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TOIIWOncology Institute Inc
$ 0.1421
(127.32%)
244.05k
OMEXOdyssey Marine Exploration Inc
$ 0.9047
(112.42%)
157.28M
CEPCantor Equity Partners Inc
$ 27.94
(69.33%)
37.35M
AREBAmerican Rebel Holdings Inc
$ 4.31
(40.39%)
69.76M
CEROCERo Therapeutics Holdings Inc
$ 1.08
(35.10%)
64.51M
GNLNGreenlane Holdings Inc
$ 0.0163
(-93.36%)
251.98M
JZXNJiuzi Holdings Inc
$ 2.18
(-70.54%)
991.1k
OCEAOcean Biomedical Inc
$ 0.0108
(-47.32%)
72.82M
AGMHAGM Group Holdings Inc
$ 0.0423
(-27.07%)
25.27M
NCNANuCana PLC
$ 0.6589
(-25.97%)
490.29k
DMNDamon Inc
$ 0.0035
(-14.63%)
261.37M
GNLNGreenlane Holdings Inc
$ 0.0163
(-93.36%)
251.98M
LRHCLa Rosa Holdings Corporation
$ 0.1611
(31.94%)
158.47M
OMEXOdyssey Marine Exploration Inc
$ 0.9047
(112.42%)
157.28M
CNEYCN Energy Group Inc
$ 0.1533
(20.61%)
151.08M

MASS Discussion

View Posts
makinezmoney makinezmoney 2 months ago
$MASS: Repligen purchases sending $MASS

Now at $3.30


We've announced that @Repligen has purchased our bioprocessing PAT portfolio including our MAVERICK, MAVEN, REBEL & ZipChip devices. We are now fully focused on serving vital health and safety applications with our newly expanded handheld device portfolio. https://t.co/8ayBstxGDp pic.twitter.com/GcOpPEMsvQ— 908 Devices (@908Devices) March 4, 2025


Nice moves but still a Net Operating Loss so I dont know if this will stick around.
Gotta get those expenses under control.


GO $MASS
👍️0
TheFinalCD TheFinalCD 2 months ago
Transaction Terms and Advisors

The purchase consideration is a payment of $70 million in cash. Centerview Partners LLC is acting as financial advisor and Goodwin Procter is serving as legal counsel to Repligen Corporation. Perella Weinberg Partners is acting as financial advisor and Paul Hastings LLP is serving as legal counsel to 908 Devices Inc.
https://www.businesswire.com/news/home/20250304869460/en
👍️0
TheFinalCD TheFinalCD 2 months ago
Transaction Terms and Advisors

The purchase consideration is a payment of $70 million in cash. Centerview Partners LLC is acting as financial advisor and Goodwin Procter is serving as legal counsel to Repligen Corporation. Perella Weinberg Partners is acting as financial advisor and Paul Hastings LLP is serving as legal counsel to 908 Devices Inc.
https://www.businesswire.com/news/home/20250304869460/en
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
MASS ready for 3.40
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
MASS MONSTER
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
MASS GOING TO BE MASSIVE
👍️0
tw0122 tw0122 3 months ago
Invisible works $2.42 + 20%
👍️0
Monksdream Monksdream 5 months ago
MASS, new 52 week low
👍️0
Monksdream Monksdream 8 months ago
MASS new 52 low
👍️0
Monksdream Monksdream 8 months ago
MASS new 52=week high
👍️0
Monksdream Monksdream 8 months ago
MASS new 52 week low
👍️0
Monksdream Monksdream 8 months ago
MASS new 52 week low
👍️0
Monksdream Monksdream 1 year ago
MASS 10Q due March 5
👍️0
Monksdream Monksdream 2 years ago
From that awful Cathie Wood
908 Devices (MASS)
icon-rise-1
22%
Shares of 908 Devices traded up ~22% on Tuesday after the company released5 its second-quarter results in which revenues rose 9% on a year-over-year basis, surprising on the high side of expectations. 908 Devices is a life sciences tools company that miniaturizes mass spectrometry to decentralize chemical and biomolecular analyses.
👍️0

Your Recent History

Delayed Upgrade Clock